← Leaderboards
Eric S Ubil
University Of Alabama At Birmingham
$1,824,622
Attributed
$1,824,622
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500.7K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,824,622 · 2
By mechanism
R01$1,247,566 · 1
K22$577,056 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Bradley K. Yoder$32,312,462
- Eric Hunter$78,178,241
- Joseph D Puglisi$32,985,038
- Anindya Dutta$22,040,743
- Erwin G Van Meir$28,591,922
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingMacrophage ActivationImmune TargetingMalignant NeoplasmsLigandsMacrophageImmuneImmune ResponseImmunotherapyInnate Immune CheckpointCtla4 GeneIn VivoComplexCombined Modality TherapyAffectGeneticImmune ActivationImmune CheckpointAdaptor Signaling ProteinImmunosuppressionInflammatory ResponseInflammatoryAdaptive Immune ResponseNeoplastic Cell
Grant awards (7)
PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy$333,073
R01 · FY2025 · CA · contact PI
PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy$304,110
R01 · FY2024 · CA · contact PI
PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy$301,996
R01 · FY2023 · CA · contact PI
PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy$308,387
R01 · FY2022 · CA · contact PI
Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis$192,352
K22 · FY2022 · CA · contact PI
Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis$192,352
K22 · FY2021 · CA · contact PI
Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis$192,352
K22 · FY2020 · CA · contact PI